Home › Funds › CLOUGH CAPITAL PARTNERS L P › CRSP

CLOUGH CAPITAL PARTNERS L P position in CRSP

CRISPR THERAPEUTICS AG · Health Care

CLOUGH CAPITAL PARTNERS L P reported holding 98,337 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q2 2026 13F filing — a position valued at US$5.4M, representing 0.45% of its reported portfolio and ranking #48 among its reported holdings. CLOUGH CAPITAL PARTNERS L P has disclosed CRSP holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)98.34K sh
Reported value held$5.36M
Portfolio Weight0.45%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CLOUGH CAPITAL PARTNERS L P's CRSP position evolved

CLOUGH CAPITAL PARTNERS L P first disclosed a stake in CRSP in Q4 2023 at 5,226 shares (US$327K). The position peaked in Q2 2026 at 98,337 shares, worth US$5.4M. Across 6 filings, CLOUGH CAPITAL PARTNERS L P increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 98,337 shares valued at US$5.4M — an increase of 75,337 shares quarter over quarter.. Notable position changes include a 328% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 5.23K $327.15K New
Q2 2024 20.94K $1.13M New
Q4 2024 57.20K $2.25M New
Q3 2025 23.00K $1.49M New
Q4 2025 23.00K $1.21M Hold
Q2 2026 98.34K $5.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRSP and 13F data

CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 32 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$175.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRSP

All CRSP fund holders →

FAQ

How long has CLOUGH CAPITAL PARTNERS L P held CRSP?

CLOUGH CAPITAL PARTNERS L P has disclosed CRSP holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

What is CLOUGH CAPITAL PARTNERS L P's current position in CRSP?

As of Q2 2026, CLOUGH CAPITAL PARTNERS L P holds 98.34K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $5.36M, representing 0.45% of its reported portfolio and ranking #48.

Has CLOUGH CAPITAL PARTNERS L P been buying or selling CRSP?

In the latest 13F filing (Q2 2026), CLOUGH CAPITAL PARTNERS L P increased its position in CRSP. The position peaked in Q2 2026 at 98.34K shares.

Which other funds hold CRSP?

Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.